FDA-Approved Cancer Drug Fedratinib Reshapes How Cell Organelles Communicate, Providing New Therapeutic Avenues
Researchers at the University of Michigan have discovered that the FDA-approved drug Fedratinib may promote communication between two critical cellular organelles—the endoplasmic reticulum and mitochondria—offering new insights into cellular metabolism and potential therapeutic strategies for…